The Clinical Study On Xiang A1, Xiang A2, Anti-Viral Combination Therapy In Patients Incidence Of Aids

Objective View xiang A, granule and incidence of AIDS among HAART therapy combined with applied total score of clinical symptoms, CD4+T cells and viral load effect.Methods:In this study, more than AIDS, according to Hunan Province, the experience of clinical experts, Screened out xiangA1, xiangA2 granules, application of multi-center, randomized, controlled, double-blind testing methods, Combined it with the antiviral drugs, intervention effect on HIV incidence in patients.Results Total score of symptoms after treatment, compared among the groups, A comparison group and B group, P=0.766, P>0.05, A group B no significant difference between groups; A group, C group and B group. C group comparisons between, P<0.05, May be that A, B group of patients during the treatment of AIDS incidence, the improvement of symptoms and signs better than the control group C group.After treatment, CD4-T cell count between the groups compared, A group, B group (P=0.032) with the A group, C (P=0.04) compared, P< 0.05,A group and B group comparison between the two groups, A group and C group comparison between the two groups, there were significant differences; Between B group and C group compared, P=0.452,P> 0.05, that the B group and C group compared, no significant difference.Viral load after treatment, compared among the groups, A group and B group comparison between the two groups, P=0.959,P> 0.05, A group and B group was not significant between the two groups; A group, C group (P=0.002) and B group, C group (P=0.003) comparisons between, P<0.05, that the A group, B group of patients during the treatment of AIDS incidence, The effect of reducing viral load than the control group C group.Before and after treatment in each group compared the safety index, each group P>0.05, there is no significant difference, It can be seen between the safety index of each group were no significant differences thus we can say that Xiang A granule for AIDS incidence in Patients relative safety.Conclusion:It follows that, Xiang A granule has a role in improving clinical symptoms and signs, regulating immune function in AIDS patients, to reduce the side effects caused by antiretroviral therapy and supporting reducing viral load,etc.